Cargando…

Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome

BACKGROUND: Several evidences suggested that ovarian cancer (OC) patients showing isolated lymph node recurrence (ILNR) have an indolent evolution. The aim of the study was to retrospectively review ILNR observed in our Institution over the past 11 years in order to investigate: the pattern of disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Legge, Francesco, Petrillo, Marco, Adamo, Vincenzo, Pisconti, Salvatore, Scambia, Giovanni, Ferrandina, Gabriella
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632673/ https://www.ncbi.nlm.nih.gov/pubmed/19077269 http://dx.doi.org/10.1186/1471-2407-8-367

Ejemplares similares

Radiomic models for lymph node metastasis prediction in cervical cancer: can we think beyond sentinel lymph node?
por: Bizzarri, Nicolò, et al.
Publicado: (2021)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
por: Legge, Francesco, et al.
Publicado: (2011)

Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report
por: Corrado, Giacomo, et al.
Publicado: (2010)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

The role of apparent diffusion coefficient (ADC) in the evaluation of lymph node status in patients with locally advanced cervical cancer: our experience and a review
por: Gui, Benedetta, et al.
Publicado: (2022)

Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series
por: Bizzarri, Nicolò, et al.
Publicado: (2020)

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
por: Mascilini, Floriana, et al.
Publicado: (2014)

Conservatively treated glassy cell carcinoma of the cervix
por: Ferrandina, Gabriella, et al.
Publicado: (2008)

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
por: Ferrandina, Gabriella, et al.
Publicado: (2014)

Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment
por: Ciucci, Alessandra, et al.
Publicado: (2016)

Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
por: Marone, M., et al.
Publicado: (1996)

Isolated tumour cells in a sentinel lymph node of apparent early-stage ovarian cancer: Ultrastaging of all other 27 lymph nodes
por: Uccella, Stefano, et al.
Publicado: (2022)

Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse
por: Hollis, Robert L., et al.
Publicado: (2019)

Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study
por: Federico, Alex, et al.
Publicado: (2022)

Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature
por: Ferrandina, Gabriella, et al.
Publicado: (2006)

Femur metastasis in carcinoma of the uterine cervix: a rare entity
por: Corrado, Giacomo, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study
por: Adamo, V, et al.
Publicado: (2008)

Role of blue dye for sentinel lymph node detection in early endometrial cancer
por: Restaino, Stefano, et al.
Publicado: (2017)

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2006)

Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral centre and review of the literature
por: Turco, Luigi Carlo, et al.
Publicado: (2020)

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters
por: Ferrandina, G, et al.
Publicado: (2005)

Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?
por: Baranello, Cinzia, et al.
Publicado: (2012)

Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?
por: Imterat, Majdi, et al.
Publicado: (2021)

Author's reply to: What is the prognostic importance of lymphovascular space invasion in the absence of lymph node metastasis for early-stage endometrial cancer?
por: Tortorella, Lucia, et al.
Publicado: (2021)

MiR-200c and HuR in ovarian cancer
por: Prislei, Silvia, et al.
Publicado: (2013)

Feasibility of Sentinel Lymph Node Biopsy in Early-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Zachou, Georgia, et al.
Publicado: (2023)

hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
por: Ercoli, A, et al.
Publicado: (1999)

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients
por: Lorusso, D, et al.
Publicado: (2012)

Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control
por: Petrillo, Marco, et al.
Publicado: (2016)

Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
por: Ferrandina, G, et al.
Publicado: (2008)

Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis
por: Mantegna, Giovanna, et al.
Publicado: (2013)

Role of Extracellular Vesicles in Epithelial Ovarian Cancer: A Systematic Review
por: Lucidi, Alessandro, et al.
Publicado: (2020)

Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study
por: Corrado, Giacomo, et al.
Publicado: (2020)

Sentinel Lymph Node in Aged Endometrial Cancer Patients “The SAGE Study”: A Multicenter Experience
por: Cianci, Stefano, et al.
Publicado: (2021)

Lymph Nodes Involvement and Lymphadenectomy in Thymic Tumors: Tentative Answers for Unsolved Questions
por: Brascia, Debora, et al.
Publicado: (2021)

Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
por: Pothuri, Bhavana, et al.
Publicado: (2010)

Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer
por: Petrillo, Marco, et al.
Publicado: (2015)

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
por: Umemoto, M, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_e71hc3953muapitr4fu80k4tp8